Sign in to view content

Short-term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits

William E. Smiddy, MD

Video
Published 2021

Related

Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2021
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Nonneovascular Age Related Macular Degeneration and Fluid
David Sarraf, MD
Annual Meeting Talks
2020

Category: Risk Management

See more